Hydroxypropylamines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 17, 2007
Grant Date -
Jul 3, 2003
app pub date -
Oct 4, 2002
filing date -
Oct 4, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed are compounds of formula I: ##STR00001## and the pharmaceutically acceptable salts thereof wherein the variables R.sub.N, R.sub.1, R.sub.2, R.sub.3, R.sub.P and R.sub.C are defined herein. These compounds are useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully